content tagged with phase 3 clinical trials

CoronaVac is 83.5 percent effective, says Turkey’s Hacettepe University

COVID-19

CoronaVac is 83.5 percent effective, says Turkey’s Hacettepe University

Turkey’s Ankara-based Hacettepe University has shared the results of the Phase 3 clinical trials of Sinovac company's coronavirus vaccine. The vaccine will prevent hospitalization by 100 percent, according to the university.